{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:47:04Z","timestamp":1794642424830,"version":"4.9.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>Background and Aim:<\/jats:title>\n            <jats:p>The etiology of liver diseases has changed in recent years, but its impact on the comparative burden of liver cancer between males and females is unclear. We estimated sex differences in the burden of liver cancer across 204 countries and territories from 2010 to 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Approach and Result:<\/jats:title>\n            <jats:p>We analyzed temporal trends in the burden of liver cancer using the methodology framework of the 2019 Global Burden of Disease study. We estimated annual frequencies and age\u2010standardized rates (ASRs) of liver cancer incidence, death, and disability\u2010adjusted life\u2010years (DALYs) by sex, country, region, and etiology of liver disease. Globally in 2019, the frequency of incident cases, deaths, and DALYs due to liver cancer were 376,483, 333,672, and 9,048,723 in males, versus 157,881, 150,904, and 3,479,699 in females. From 2010 to 2019, the incidence ASRs in males increased while death and DALY ASRs remained stable; incidence, death, and DALY ASRs in females decreased. Death ASRs for both sexes increased only in the Americas and remained stable or declined in remaining regions. In 2019, hepatitis B was the leading cause of liver cancer death in males, and hepatitis C in females. From 2010 to 2019, NASH had the fastest growing death ASRs in males and females. The ratio of female\u2010to\u2010male death ASRs in 2019 was lowest in hepatitis B (0.2) and highest in NASH (0.9).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The overall burden of liver cancer is higher in males, although incidence and death ASRs from NASH\u2010associated liver cancer in females approach that of males.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.32758","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T14:09:31Z","timestamp":1661782171000},"page":"1150-1163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":139,"title":["Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH"],"prefix":"10.1097","volume":"77","author":[{"given":"Darren Jun Hao","family":"Tan","sequence":"first","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica Wendy","family":"Setiawan","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-1569","authenticated-orcid":false,"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Hui","family":"Lim","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Muthiah","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice X.","family":"Tan","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yock Young","family":"Dan","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-9991","authenticated-orcid":false,"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, California, USA"},{"name":"Division of Epidemiology, Department of Family Medicine and Public Health, University of California at San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-5061","authenticated-orcid":false,"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"},{"name":"NAFLD Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"hep32758-bib-0001-20250824","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"hep32758-bib-0002-20250824","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"hep32758-bib-0003-20250824","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"hep32758-bib-0004-20250824","article-title":"Hepatocellular carcinoma","volume":"7","year":"2021","journal-title":"Nat Rev Disease Primers"},{"key":"hep32758-bib-0005-20250824","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","year":"2022","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"hep32758-bib-0006-20250824","first-page":"5","article-title":"Hepatitis B: who to treat? A critical review of international guidelines","volume":"40","year":"2020","journal-title":"Liver Int"},{"key":"hep32758-bib-0007-20250824","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta\u2010analysis","volume":"63","year":"2016","journal-title":"Hepatology"},{"key":"hep32758-bib-0008-20250824","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMra1810477","article-title":"Global elimination of chronic hepatitis","volume":"380","year":"2019","journal-title":"N Engl J Med"},{"key":"hep32758-bib-0009-20250824","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice","volume":"13","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32758-bib-0010-20250824","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/liv.14877","article-title":"Differential characteristics and outcomes of Asian and non\u2010Asian patients with HBV\u2010related hepatocellular carcinoma","volume":"41","year":"2021","journal-title":"Liver Int"},{"key":"hep32758-bib-0011-20250824","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","year":"2021","journal-title":"Cell"},{"key":"hep32758-bib-0012-20250824","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2020.03.049","article-title":"Risk factors for cirrhosis in contemporary hepatology practices\u2010findings from the texas hepatocellular carcinoma consortium cohort","volume":"159","year":"2020","journal-title":"Gastroenterology"},{"key":"hep32758-bib-0013-20250824","article-title":"2019 global NAFLD prevalence\u2014a systematic review and meta\u2010analysis","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32758-bib-0014-20250824","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non\u2010alcoholic fatty liver disease\u2010related hepatocellular carcinoma: a systematic review and meta\u2010analysis","volume":"23","year":"2022","journal-title":"Lancet Oncol"},{"key":"hep32758-bib-0015-20250824","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD\u2010related HCC: trends, predictions, risk factors and prevention","volume":"18","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep32758-bib-0016-20250824","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"hep32758-bib-0017-20250824","article-title":"Alcoholic liver disease","volume":"4","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"hep32758-bib-0018-20250824","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1002\/cncr.28912","article-title":"Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis","volume":"120","year":"2014","journal-title":"Cancer"},{"key":"hep32758-bib-0019-20250824","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2006-939841","article-title":"Epidemiology of primary and secondary liver cancers","volume":"23","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"hep32758-bib-0020-20250824","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88\u2010dependent IL\u20106 production","volume":"317","year":"2007","journal-title":"Science"},{"key":"hep32758-bib-0021-20250824","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jhep.2020.05.043","article-title":"Risk of hepatocellular carcinoma in Danish outpatients with alcohol\u2010related cirrhosis","volume":"73","year":"2020","journal-title":"J Hepatol"},{"key":"hep32758-bib-0022-20250824","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2018.07.018","article-title":"Modified PAGE\u2010B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"hep32758-bib-0023-20250824","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta\u2010analysis, and meta\u2010regression","volume":"20","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32758-bib-0024-20250824","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cgh.2018.10.031","article-title":"Hepatocellular carcinoma screening is associated with increased survival of patients with cirrhosis","volume":"17","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32758-bib-0025-20250824","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy\u2010confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","year":"2021","journal-title":"Gut"},{"key":"hep32758-bib-0026-20250824","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the Global Burden of Chronic Liver Diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","year":"2020","journal-title":"Hepatology"},{"key":"hep32758-bib-0027-20250824","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015","volume":"3","year":"2017","journal-title":"JAMA Oncol"},{"key":"hep32758-bib-0028-20250824","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"hep32758-bib-0029-20250824","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions\u20102019\u20132030","volume":"51","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"hep32758-bib-0030-20250824","first-page":"195","article-title":"Rational HCC screening approaches for patients with NAFLD","volume":"76","year":"2021","journal-title":"J Hepatol"},{"key":"hep32758-bib-0031-20250824","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/apt.16844","article-title":"Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: a prospective study","volume":"55","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"hep32758-bib-0032-20250824","article-title":"NAFLD versus MAFLD: prevalence, outcomes and implications of a change in name","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"hep32758-bib-0033-20250824","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus\u2010driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","year":"2020","journal-title":"Gastroenterology"},{"key":"hep32758-bib-0034-20250824","article-title":"The global burden of disease attributable to high body mass index in 195 countries and territories, 1990\u20132017: an analysis of the Global Burden of Disease Study","volume":"17","year":"2020","journal-title":"PLoS Med"},{"key":"hep32758-bib-0035-20250824","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amepre.2011.10.026","article-title":"Obesity and severe obesity forecasts through 2030","volume":"42","year":"2012","journal-title":"Am J Prev Med"},{"key":"hep32758-bib-0036-20250824","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41574-020-00411-y","article-title":"Nearly a decade on\u2014trends, risk factors and policy implications in global obesity","volume":"16","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"hep32758-bib-0037-20250824","article-title":"Modelling future trajectories of obesity and body mass index in England","volume":"16","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"hep32758-bib-0039-20250824","first-page":"60","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"hep32758-bib-0040-20250824","article-title":"Diabetes and racial\/ethnic differences in hepatocellular carcinoma risk: the multiethnic cohort","volume":"106","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"hep32758-bib-0041-20250824","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.30858","article-title":"Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease","volume":"71","year":"2020","journal-title":"Hepatology"},{"key":"hep32758-bib-0042-20250824","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","article-title":"Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase","volume":"20","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32758-bib-0043-20250824","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/hep.30988","article-title":"Cure with interferon\u2010free direct\u2010acting antiviral is associated with increased survival in patients with hepatitis C virus\u2013related hepatocellular carcinoma from both East and West","volume":"71","year":"2020","journal-title":"Hepatology"},{"key":"hep32758-bib-0044-20250824","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2015.11.006","article-title":"Alcohol and liver disease in Europe\u2014simple measures have the potential to prevent tens of thousands of premature deaths","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"hep32758-bib-0045-20250824","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real\u2010world study of 18 million patients in four European cohorts","volume":"17","year":"2019","journal-title":"BMC Med"},{"key":"hep32758-bib-0046-20250824","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non\u2010alcoholic fatty liver disease","volume":"155","year":"2018","journal-title":"Gastroenterology"},{"key":"hep32758-bib-0047-20250824","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1111\/liv.15357","article-title":"Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory","volume":"42","year":"2022","journal-title":"Liver Int"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.32758","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.32758","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:09:19Z","timestamp":1756073359000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.32758","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"2022-07-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}